Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients.

Current Pharmaceutical Design
Nimmy Kumari, Animesh Ghosh

Abstract

Cocrystallization is a widely accepted and clinically relevant technique that has prospered very well over the past decades to potentially modify the physicochemical properties of existing active pharmaceutic ingredients (APIs) without compromising their therapeutic benefits. Over time, it has become an integral part of the pre-formulation stage of drug development because of its ability to yield cocrystals with improved properties in a way that other traditional methods cannot easily achieve. Cocrystals are solid crystalline materials composed of two or more than two molecules which are non-covalently bonded in the same crystal lattice. Due to the continuous efforts of pharmaceutical scientists and crystal engineers, today cocrystals have emerged as a cutting edge tool to modulate poor physicochemical properties of APIs such as solubility, permeability, bioavailability, improving poor mechanical properties and taste masking. The success of cocrystals can be traced back by looking at the number of products that are getting regulatory approval. At present, many cocrystals have obtained regulatory approval and they successfully made into the market place followed by a fair number of cocrystals that are currently in the clinical p...Continue Reading

References

Jun 1, 1991·Pharmaceutical Research·M Y LuM Vadnere
Jun 29, 2000·Drug Development and Industrial Pharmacy·R AgarwalA Singh
May 31, 2002·Acta Crystallographica. Section B, Structural Science·Frank H Allen
Oct 1, 1959·American Journal of Pharmacy and the Sciences Supporting Public Health·J W POOLE, T HIGUCHI
Mar 17, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Swati Rawat, Sanjay K Jain
Mar 27, 2004·Chemical Communications : Chem Comm·Andrew V TraskWilliam Jones
Nov 27, 2004·The Journal of Pharmacy and Pharmacology·LianDong HuFuDe Cui
Sep 28, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J Szejtli, L Szente
Mar 17, 2006·Ultrasonics Sonochemistry·Hong LiYu Liu
Jun 6, 2006·Molecular Pharmaceutics·Naír Rodríguez-HornedoChristopher J Falkiewicz
Jun 14, 2006·International Journal of Pharmaceutics·Andrew V TraskWilliam Jones
Jul 13, 2006·Pharmaceutical Research·Daniel P McNamaraAeri Park
Feb 13, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Magali B HickeyOrn Almarsson
Mar 14, 2007·Acta Crystallographica. Section C, Crystal Structure Communications·William T A Harrison Devaraju
Apr 25, 2007·Journal of Pharmaceutical Sciences·M DescampsV Caron
May 5, 2007·Molecular Pharmaceutics·Andrew V Trask
May 15, 2007·Molecular Pharmaceutics·Shyam KarkiW D Samuel Motherwell
Jul 10, 2007·Advanced Drug Delivery Reviews·Abu T M Serajuddin
May 19, 2009·International Journal of Pharmaceutics·Abigail AinouzHarvey Lieberman
Sep 24, 2009·Journal of Pharmaceutical Sciences·Cesar MedinaFernando Alvarez-Nunez
May 8, 2010·Chemical Communications : Chem Comm·Katharina Bica, Robin D Rogers
Aug 31, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Suyog AherPeter York
Sep 28, 2010·Pharmaceutical Research·Ravindra S DhumalAnant Paradkar
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Min-Sook JungSitaram P Velaga
Aug 11, 2011·International Journal of Pharmaceutics·Ning QiaoGary Trappitt
May 23, 2012·Chemistry, an Asian Journal·N Jagadeesh BabuAshwini Nangia
Oct 12, 2012·AAPS PharmSciTech·Courtney A Ober, Ram B Gupta
Jan 3, 2013·The Journal of Pharmacy and Pharmacology·Jinu IsaacAnimesh Ghosh
Mar 5, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nan-Hee ChunGuang J Choi
Jun 25, 2013·Drug Development and Industrial Pharmacy·Tetsuo OgataTetsuya Ozeki
Dec 4, 2013·Chemical Communications : Chem Comm·Jian-Rong WangXuefeng Mei
Jan 1, 2011·Pharmaceutics·Sönke RehderClaudia S Leopold
Jan 18, 2014·The Journal of Pharmacy and Pharmacology·Lien SaerensThomas De Beer
Jun 7, 2014·Journal of Pharmaceutical Sciences·Yanting HuangLimin Shi
Jul 6, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jan HolaňLuděk Ridvan
Jul 11, 2014·International Journal of Pharmaceutics·Yusuke MaenoKazuo Tomono
Nov 6, 2014·Angewandte Chemie·Dejan-Krešimir BučarWilliam Jones
Feb 13, 2015·Chemical Communications : Chem Comm·C C WeberA S Myerson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.